Economic Evaluation in Ethiopian Healthcare Sector Decision Making: Perception, Practice and Barriers

Abstract

Background

Globally, economic evaluation (EE) is increasingly being considered as a critical tool for allocating scarce healthcare resources. However, such considerations are less documented in low-income countries, such as in Ethiopia. In particular, to date there has been no assessment conducted to evaluate the perception and practice of and barriers to health EE.

Objective

This paper assesses the use and perceptions of EE in healthcare decision-making processes in Ethiopia.

Methods

In-depth interview sessions with decision makers/healthcare managers and program coordinators across six regional health bureaus were conducted. A qualitative analysis approach was conducted on three thematic areas.

Results

A total of 57 decision makers/healthcare managers were interviewed from all tiers of the health sector in Ethiopia, ranging from the Federal Ministry of Health down to the lower levels of the health facility pyramid. At the high-level healthcare decision-making tier, only 56 % of those interviewed showed a good understanding of EE when explaining in terms of cost and consequences of alternative courses of action and value for money. From the specific program perspective, 50 % of the prevention of mother-to-child transmission of HIV/AIDS program coordinators indicated the relevance of EE to program planning and decision making. These respondents reported a limited application of costing studies on the HIV/AIDS prevention and control program, which were most commonly used during annual planning and budgeting.

Conclusion

The study uncovered three important barriers to growth of EE in Ethiopia: a lack of awareness, a lack of expertise and skill, and the traditional decision-making culture.

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2

References

  1. 1.

    O’Brien B. Principles of economic evaluation for health care programs. J Rheumatol. 1995;22(7):1399–402.

    PubMed  Google Scholar 

  2. 2.

    Eddama O, Coast J. A systematic review of the use of economic evaluation in local decision-making. Health Policy. 2008;86(2–3):129–41.

    Article  PubMed  Google Scholar 

  3. 3.

    Ross J. The use of economic evaluation in health care: Australian decision makers’ perceptions. Health Policy. 1995;31(2):103–10.

    CAS  Article  PubMed  Google Scholar 

  4. 4.

    Bryan S, Williams I, McIver S. Seeing the NICE side of cost-effectiveness analysis: a qualitative investigation of the use of CEA in NICE technology appraisals. Health Economics. 2007;16(2):179–93.

    Article  PubMed  Google Scholar 

  5. 5.

    Brousselle A, Lessard C. Economic evaluation to inform health care decision-making: promise, pitfalls and a proposal for an alternative path. Soc Sci Med. 2011;72(6):832–9.

    Article  PubMed  Google Scholar 

  6. 6.

    Drummond M, Brandt A, Luce B, Rovira J. Standardizing methodologies for economic evaluation in health care: practice, problems, and potential. Int J Technol Assess Health Care. 1993;9(01):26–36.

    CAS  Article  PubMed  Google Scholar 

  7. 7.

    Drummond M. Economic evaluation and the rational diffusion and use of health technology. Health Policy. 1987;7(3):309–24.

    CAS  Article  PubMed  Google Scholar 

  8. 8.

    Yothasamut J, Tantivess S, Teerawattananon Y. Using economic evaluation in policy decision-making in Asian countries: mission impossible or mission probable? Value Health. 2009;12(SUPPL. 3):S26–30.

    Article  PubMed  Google Scholar 

  9. 9.

    Gavaza P, Rascati KL, Oladapo AO, Khoza S. The state of health economic evaluation research in Nigeria. Pharmacoeconomics. 2010;28(7):539–53.

    PubMed  Google Scholar 

  10. 10.

    Gavaza P, Rascati KL, Oladapo AO, Khoza S. PHP46 The state of health economic evaluation in South Africa: a systematic review. Value Health. 2011;14(3):A19.

    Article  Google Scholar 

  11. 11.

    Gavaza P, Rascati KL, Lawson KA, Brown CM, Mann T. PHP48 The state of health economics and pharmacoeconomics evaluation research in Zimbabwe. Value Health. 2008;11(3):A43.

    Article  Google Scholar 

  12. 12.

    Gavaza P, Rascati K, Oladapo AO, Khoza S. PHP80 The state of health economics and pharmaceoconomics evaluation research in Nigeria: a systematic review. Value Health. 2010;13(3):A96.

    Article  Google Scholar 

  13. 13.

    Lessard C, Contandriopoulos AP, Beaulieu MD. The role (or not) of economic evaluation at the micro level: can Bourdieu’s theory provide a way forward for clinical decision-making? Soc Sci Med. 2010;70(12):1948–56.

    Article  PubMed  Google Scholar 

  14. 14.

    Williams I, McIver S, Moore D, Bryan S. The use of economic evaluations in NHS decision-making: a review and empirical investigation. Clin Gov Int J. 2008;13(3).

  15. 15.

    Hoffmann C, von der Schulenburg JMG. The influence of economic evaluation studies on decision making: a European survey. Health Policy. 2000;52(3):179–92.

    CAS  Article  PubMed  Google Scholar 

  16. 16.

    Merlo G, Page K, Ratcliffe J, Halton K, Graves N. Bridging the gap: exploring the barriers to using economic evidence in healthcare decision making and strategies for improving uptake. Appl Health Econ Health Policy. 2015;13(3):303–9.

    Article  PubMed  Google Scholar 

  17. 17.

    Fasawe O, Avila C, Shaffer N, Schouten E, Chimbwandira F, Hoos D, et al. Cost-effectiveness analysis of option B+ for HIV prevention and treatment of mothers and children in Malawi. PloS one. 2013;8(3):e57778.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  18. 18.

    Shah M, Johns B, Abimiku AL, Walker DG. Cost-effectiveness of new WHO recommendations for prevention of mother-to-child transmission of HIV in a resource-limited setting. Acquir Immune Defic Syndr. 2011;25(8):1093–102.

    Google Scholar 

  19. 19.

    Söderlund N, Zwi K, Kinghorn A, Gray G. Prevention of vertical transmission of HIV: analysis of cost effectiveness of options available in South Africa. BMJ. 1999;318(7199):1650–6.

    Article  PubMed  PubMed Central  Google Scholar 

  20. 20.

    Ciaranello AL, Perez F, Maruva M, Chu J, Engelsmann B, Keatinge J, et al. WHO 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe: modeling clinical outcomes in infants and mothers. PloS One. 2011;6(6):e20224.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  21. 21.

    Kuznik A, Lamorde M, Hermans S, Castelnuovo B, Auerbach B, Semeere A, et al. Evaluating the cost-effectiveness of combination antiretroviral therapy for the prevention of mother-to-child transmission of HIV in Uganda. Bull World Health Organ. 2012;90(8):595–603.

    Article  PubMed  PubMed Central  Google Scholar 

  22. 22.

    Ministry of Finance and Economic Development (MoFED). The Federal Democratic Republic of Ethiopia: Growth and Transformation Plan (GTP) 2010/11–2014/15. Addis Ababa: Ethiopia Ministry of Finance and Economic Development; 2010.

  23. 23.

    Federal Ministry of Health (FMOH). Health Sector Transformation Plan (HSTP) 2015/16–2019/20. Addis Ababa: Ethiopia Federal Ministry of Health; 2015.

  24. 24.

    Federal Ministry of Health (FMOH). Health Sector Development Programme (HSDP IV) 2010/11–2014/15. Addis Ababa: Ethiopia Federal Ministry of Health; 2010.

  25. 25.

    World Health Orgnization. WHO. Geneva: World Health Statistics, World Health Organization; 2014.

    Google Scholar 

  26. 26.

    Wang H, Ramana GNV. Ethiopia—Universal health coverage for inclusive and sustainable development: country summary report: Washington DC; 2014.

  27. 27.

    Koblinsky M, Tain F, Gaym A, Karim A, Carnell M, Tesfaye S. Responding to the maternal health care challenge: the Ethiopian Health Extension Program. Ethiop J Health Dev. 2010;24(1).

  28. 28.

    Federal Ministry of Health (FMOH). Health Management Information System (HMIS) Information User Guide. Addis Ababa: Ethiopia Federal Ministry of Health; 2013.

  29. 29.

    European AIDS treatment group (EATG). News:Globl Fund and Financial Slack and proposed cuts. 2010.http://www.eatg.org/news/154866/Evidence_grows:_Global_Fund_financial_slack_and_proposed_cuts_to_PEPFAR_are_hurting_progress_against_AIDS. Accessed 12 May 2014.

  30. 30.

    Federal Ministry of Health (FMOH). Ethiopia’s Fifth National Health Accounts 2010/2011. Addis Ababa: Ethiopia Federal Ministry of Health; 2014.

  31. 31.

    Organisation of African Unity (OAU). Abuja declaration on HIV/AIDS, tuberculosis, and other related infectious diseases. OAU/SPS/ Abuja/3: New York. United Nations; 2001.

  32. 32.

    Bikilla AD, Jerene D, Robberstad B, Lindtjorn B. Cost estimates of HIV care and treatment with and without anti-retroviral therapy at Arba Minch Hospital in southern Ethiopia. Cost Eff Resour Alloc. 2009;7(6):1.

    Google Scholar 

  33. 33.

    Kombe G, Galaty D, Gadhia R, Decker C. Human and financial resource requirements for scaling up HIV/AIDS services in Ethiopia. Bethesda MD: The Partners for Health Reform plus Project Abt Associates Inc; 2004.

    Google Scholar 

  34. 34.

    Johns B, Asfaw E, Wong W, Bekele A, Minior T, Kebede A, et al. Assessing the costs and effects of antiretroviral therapy task shifting from physicians to other health professionals in Ethiopia. Acquir Immune Defic Syndr. 2014;65(4):140–7.

    Article  Google Scholar 

  35. 35.

    Asfaw E, Tushune K,Abdosh B, Pedro Paulo MC. Cost effectiveness analysis of PMTCT service delivery modalities in Addis Ababa (using decision models). Soc Sci Res Netw. http://dx.doi.org/10.2139/ssrn.2180719. Accessed 02 May 2014.

  36. 36.

    Bikilla AD, Jerene D, Robberstad B, Lindtjørn B. Cost-effectiveness of anti-retroviral therapy at a district hospital in southern Ethiopia. Cost Eff Resour Alloc. 2009;7(13):1.

    Google Scholar 

  37. 37.

    Federal HIV/AIDS Prevention and Control Office (FHAPCO). Facility-based anti-retroviral treatment costing study in Ethiopia. Addis Ababa: Ethiopia Federal HIV/AIDS Prevention and Control Office/Ethiopia Federal Ministry of Health; 2012.

  38. 38.

    Creswell JW, Clark VL. Designing and conducting mixed method research. 2nd ed. USA: SAGE Publications Inc; 2011.

    Google Scholar 

  39. 39.

    Bryman A. Social research methods. 4th ed. New York: Oxford University Press; 2012.

    Google Scholar 

  40. 40.

    Coast J. The appropriate uses of qualitative methods in health economics. Health Econ. 1999;8(4):345–53.

    CAS  Article  PubMed  Google Scholar 

  41. 41.

    Ethiopian Public Health Institute (EPHI). Report on the 2012 round Antenatal case based sentinel surveillance in Ethiopia. Addis Ababa: Ethiopian Public Health Institute; 2014.

  42. 42.

    Patton MQ. How to use qualitative methods in evaluation. SAGE Publications Inc; 1987.

  43. 43.

    Drummond M, Sculpher M, Torrance G, O’Brien B, Stoddart GL. Methods for the economic evaluation of health care programs. 3rd ed. New York: Oxford University Press; 2005.

    Google Scholar 

  44. 44.

    Sax S. Health care choices and the public purse. Sydney: Allen and Unwin; 1990.

    Google Scholar 

  45. 45.

    Federal Ministry of Health (FMOH). Human Resource Development and Management directorate. Human resource directive and incentive package document 200-8/3/6. Addis Ababa: Ethiopian Federal Ministry of Health; 2014.

  46. 46.

    Morrison S, Brundage S. Advancing health in Ethiopia with fewer resource, an uncertian GHI strategy, and vulnerabilities on the ground. Washington DC: Centre for Strategic and International Studies; 2012.

    Google Scholar 

  47. 47.

    Resch S, Ryckman T, Hecht R. Funding AIDS programmes in the era of shared responsibility: an analysis of domestic spending in 12 low-income and middle-income countries. Lancet Glob Health. 2015;3(1):e52–61.

    Article  PubMed  Google Scholar 

  48. 48.

    Johnnesson M. Economic evaluation of health care and policymaking. Health Policy. 1995;33(3):179–90.

    Article  Google Scholar 

  49. 49.

    Hoffmann C, Stoykova BA, Nixon J, Glanville JM, Misso K, Drummond MF. Do health-care decision makers find economic evaluations useful? The findings of focus group research in UK health authorities. Value Health. 2002;5(2):71–8.

    Article  PubMed  Google Scholar 

  50. 50.

    Eddama O, Coast J. Use of economic evaluation in local health care decision-making in England: a qualitative investigation. Health Policy. 2009;89(3):261–70.

    Article  PubMed  Google Scholar 

  51. 51.

    Drummond M. Economic evaluation in health care: is it really useful or are we just kidding ourselves? Aust Econ Rev. 2004;37(1):3–11.

    Article  Google Scholar 

  52. 52.

    Wiseman V, Mitton C, Doyle-Waters MM, Drake T, Conteh L, Newall AT, et al. Using economic evidence to set healthcare priorities in low-income and lower-middle-income countries: a systematic review of methodological frameworks. Health Econ. 2016;25(S1):140–61.

    Article  PubMed  PubMed Central  Google Scholar 

  53. 53.

    Greco G, Lorgelly P, Yamabhai I. Outcomes in economic evaluations of public health interventions in low-and middle-income countries: health, capabilities and subjective wellbeing. Health Econ. 2016;25(S1):83–94.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

We would like to acknowledge the Health Economics and HIV/AIDS Economics Research Division (HEARD) at the University of KwaZulu-Natal for its supplementary financial/stipend assistance. The Federal Ministry of Health, Ethiopian Public Health Institute, Federal HIV/AIDS Prevention and Control Office, Addis Ababa City Administration Health Bureau, Dire Dawa City Administration Health Bureau, Amhara Regional Health Bureau, Oromia Regional Health Bureau, SNNP Regional Health Bureau and Harari Regional Health Bureau facilitated the data collection and provided the required evidence. We also appreciate the continuous support with English language editing services by Carol Brammage.

Author contributions

Elias Asfaw Zegeye designed the study, prepared the data collection tools, developed the analysis framework, led the data collection, analyzed the data, and drafted and revised the manuscript. Josue Mbonigaba oversaw the data collection, commented on the analysis plan, and reviewed and revised the article. Sylvia Blanche Kaye oversaw the data collection, commented on the analysis plan, and reviewed and revised the manuscript. Thomas Wilkinson commented on the overall qualitative method and revised the article.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Elias Asfaw Zegeye.

Ethics declarations

This research was funded by an African Doctoral Dissertation Research Fellowship award offered by the African Population and Health Research Centre (APHRC) in partnership with the International Development Research Center (IDRC). Elias Asfaw Zegeye, Josue Mbonigaba, Sylvia Blanche Kaye and Thomas Wilkinson have no conflicts of interest to disclose.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 81 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Zegeye, E.A., Mbonigaba, J., Kaye, S.B. et al. Economic Evaluation in Ethiopian Healthcare Sector Decision Making: Perception, Practice and Barriers. Appl Health Econ Health Policy 15, 33–43 (2017). https://doi.org/10.1007/s40258-016-0280-z

Download citation

Keywords

  • Economic Evaluation
  • Health Sector
  • Program Coordinator
  • Healthcare Decision
  • Health Economic Evaluation